MediSys

Communicable disease

Dernières nouvelles - Communicable disease

Filter by countryfromabout

<<10<12345678910>>>10

<<10<12345678910>>>10

Language Selection

For any category/filter, users can choose:

the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

country mentioned in the news item (articles about a country)
country in which the news item was published (articles from a country)

Languages

Select your languages

ab

ar

az

be

bg

bs

ca

cs

da

de

el

en

eo

es

et

fa

fi

fo

fr

ga

gl

ha

he

hi

hr

hu

hy

id

is

it

ja

ka

km

ko

ku

ky

lb

lo

lt

lv

mk

ml

mn

ms

mt

my

na

ne

nl

no

ny

os

pap

pl

ps

pt

ro

ru

se

si

sk

sl

so

sq

sr

sv

sw

ta

th

tr

tt

uk

ur

vi

zh

zxx

all

Show additional languagesHide additional languages

Interface:

Pays les plus signalés (24h)

Theme countries

Quotes... Extracted quotes

Daniel Salas said: “The vaccine we have available will not curb the dengue epidemic; it should be used complementarily with other actions. The most important actions are field operations, vector control, prevention, and education,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Jarbas Barbosa added: “The vaccines we currently have are not the best response to reduce transmission and prevent deaths,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Jarbas Barbosa said: “it is not a tool to control transmission at this moment. Studies have shown that only 8 years of [population-level] vaccination would have a significant impact on dengue transmission,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Jarbas Barbosa said: “But this vaccine will likely only be available in 2025,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Jarbas Barbosa said: “The producer, Takeda, has very limited production capacity. Brazil is the country that uses this vaccine the most, followed by Argentina. Given that these countries have a good epidemiological surveillance system and adverse effect registration, they can conduct studies on how the vaccine performs in real life, which will greatly increase our knowledge about it. For example, we will see its effectiveness against serotype 3,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Daniel Salas said: “to complete the safety and efficacy profile, especially in those who have not had dengue before and for dengue 3 and 4,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Sylvain Aldighieri noted: “not tools to control this outbreak,”

internalmedicinenews vendredi 19 avril 2024 à 22:15:00 heure d’été d’Europe centrale

Rich Pedroncelli said: “We see a wave going up and down over time, and this happens to be one of the peaks,”

philly vendredi 19 avril 2024 à 21:20:00 heure d’été d’Europe centrale

Massimo Pacilli said: "In this setting, we're observing continuing protracted exposures. And so it is not completely unexpected to see a higher proportion of individuals who may have had a dose end up being infected with measles,"

CBSnews vendredi 19 avril 2024 à 21:07:00 heure d’été d’Europe centrale

Most associated names

World Health Organization

Centers for Disease Control

Centers for Disease Control and Prevention

Securities and Exchange Commission

British government

Nasdaq Composite

Nombre d'articles par jour dans cette catégorie

Trend data not available for this selection.

Most active sources for this category

seatrade-global

blog_crofsblogs

Joint Research Centre, Home Affairs, Health and Consumers

ECDC

EFSA